Cargando…

iGEM and Gene Drives: A Case Study for Governance

Gene drives have already challenged governance systems. In this case study, we explore the International Genetically Engineered Machine (iGEM) competition's experiences in gene drive-related research and lessons in developing, revising, and implementing a governance system. iGEM's experien...

Descripción completa

Detalles Bibliográficos
Autores principales: Millett, Piers, Alexanian, Tessa, Palmer, Megan J., Evans, Sam Weiss, Kuiken, Todd, Oye, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892970/
https://www.ncbi.nlm.nih.gov/pubmed/35020492
http://dx.doi.org/10.1089/hs.2021.0157
_version_ 1784662286171897856
author Millett, Piers
Alexanian, Tessa
Palmer, Megan J.
Evans, Sam Weiss
Kuiken, Todd
Oye, Kenneth
author_facet Millett, Piers
Alexanian, Tessa
Palmer, Megan J.
Evans, Sam Weiss
Kuiken, Todd
Oye, Kenneth
author_sort Millett, Piers
collection PubMed
description Gene drives have already challenged governance systems. In this case study, we explore the International Genetically Engineered Machine (iGEM) competition's experiences in gene drive-related research and lessons in developing, revising, and implementing a governance system. iGEM's experiences and lessons are distilled into 6 key insights for future gene drive policy development in the United States: (1) gene drives deserve special attention because of their potential for widescale impact and remaining uncertainty about how to evaluate intergenerational and transboundary risks; (2) an adaptive risk management approach is logical for gene drives because of the rapidly changing technical environment; (3) review by individual technical experts is limited and may fail to incorporate other forms of expertise and, therefore, must be complemented with a range of alternative governance methods; (4) current laboratory biosafety and biosecurity review processes may not capture gene drive research or its components in practice even if they are covered theoretically; (5) risk management for research and development must incorporate discussions of values and broader implications of the work; and (6) a regular technology horizon scanning capacity is needed for the early identification of advances that could pose governance system challenges.
format Online
Article
Text
id pubmed-8892970
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-88929702022-03-03 iGEM and Gene Drives: A Case Study for Governance Millett, Piers Alexanian, Tessa Palmer, Megan J. Evans, Sam Weiss Kuiken, Todd Oye, Kenneth Health Secur Case Studies Gene drives have already challenged governance systems. In this case study, we explore the International Genetically Engineered Machine (iGEM) competition's experiences in gene drive-related research and lessons in developing, revising, and implementing a governance system. iGEM's experiences and lessons are distilled into 6 key insights for future gene drive policy development in the United States: (1) gene drives deserve special attention because of their potential for widescale impact and remaining uncertainty about how to evaluate intergenerational and transboundary risks; (2) an adaptive risk management approach is logical for gene drives because of the rapidly changing technical environment; (3) review by individual technical experts is limited and may fail to incorporate other forms of expertise and, therefore, must be complemented with a range of alternative governance methods; (4) current laboratory biosafety and biosecurity review processes may not capture gene drive research or its components in practice even if they are covered theoretically; (5) risk management for research and development must incorporate discussions of values and broader implications of the work; and (6) a regular technology horizon scanning capacity is needed for the early identification of advances that could pose governance system challenges. Mary Ann Liebert, Inc., publishers 2022-02-01 2022-02-15 /pmc/articles/PMC8892970/ /pubmed/35020492 http://dx.doi.org/10.1089/hs.2021.0157 Text en © Piers Millett et al., 2021; Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by/4.0/This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Case Studies
Millett, Piers
Alexanian, Tessa
Palmer, Megan J.
Evans, Sam Weiss
Kuiken, Todd
Oye, Kenneth
iGEM and Gene Drives: A Case Study for Governance
title iGEM and Gene Drives: A Case Study for Governance
title_full iGEM and Gene Drives: A Case Study for Governance
title_fullStr iGEM and Gene Drives: A Case Study for Governance
title_full_unstemmed iGEM and Gene Drives: A Case Study for Governance
title_short iGEM and Gene Drives: A Case Study for Governance
title_sort igem and gene drives: a case study for governance
topic Case Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892970/
https://www.ncbi.nlm.nih.gov/pubmed/35020492
http://dx.doi.org/10.1089/hs.2021.0157
work_keys_str_mv AT millettpiers igemandgenedrivesacasestudyforgovernance
AT alexaniantessa igemandgenedrivesacasestudyforgovernance
AT palmermeganj igemandgenedrivesacasestudyforgovernance
AT evanssamweiss igemandgenedrivesacasestudyforgovernance
AT kuikentodd igemandgenedrivesacasestudyforgovernance
AT oyekenneth igemandgenedrivesacasestudyforgovernance